Exhibit 2.1
-----------
PURCHASE AGREEMENT
------------------
THIS AGREEMENT is made and entered into this 15th day of June 2000, between
CYTRX CORPORATION, a Delaware corporation ("Seller"), and TITERMAX USA, INC., a
Georgia corporation ("Buyer").
In consideration of the mutual promises and agreements set forth below, the
parties agree as follows:
1. Items Purchased, Sold and Assumed.
---------------------------------
1.1 Assets. Subject to the terms and conditions contained in this
------
Agreement, on the Closing Date (as defined in Section 3 below) Seller agrees to
sell, assign and deliver to Buyer, and Buyer agrees to purchase from Seller,
free and clear of all liens and encumbrances (excluding payables describe in
Section 1.2), the following items related with and limited to Seller's TiterMax
product line (collectively, the "Items"):
(i) All TiterMax accounts receivable as of the Closing Date;
(ii) The Worldwide TiterMax trademark, which will be licensed to Buyer
pursuant to a license agreement to be entered into at Closing, at no
cost to Buyer until final note payment is made, at which time title
to such trademark will pass from Seller to Buyer;
(iii) All inventory of TiterMax components (including raw materials, less
security reserved describe in Section 6(a)), glass, vials, stoppers,
sealers, shipping boxes and labels and finished goods inventory that
are owned by CytRx;
(iv) All TiterMax marketing and promotional materials;
(v) All TiterMax customer lists including sales data and contact
information;
(vi) All currently used equipment relating to Seller's TiterMax business
including refrigerators, file cabinets, desks, two (2) computers,
printer, facsimile machine, chairs, shelves, tables, trade show
booth and TiterMax shipping equipment;
(vii) All of Seller's rights under any distributor agreements currently in
effect in all territories worldwide and distributor contracts and
databases used in operating the TiterMax brand;
(viii) All accounts in effect with current vendors and suppliers directly
related to TiterMax and to the extent they can be transferred;
(ix) All historic TiterMax records of invoices, customer files and
communications, inventory production and supplies;
(x) Seller shall provide Buyer with a license exclusive to TiterMax Gold
for the limited use as adjuvants in laboratory animals. The license
does not include any rights for research use for any other reason
including DNA delivery. This license does not include a royalty-free
license with any other party including Emory or BASF.
(xi) Seller shall provide Buyer with a sub-license to use TiterMax
Classic for the limited use as adjuvants in laboratory animals. The
license does not include any rights for research use for any other
reason, including DNA delivery. This license does not include a
royalty-free license with any other party including Emory or BASF.
1.2 Liabilities Assumed by Buyer. Buyer assumes all trade liabilities for
-----------------------------
promotion, advertising, supplies, and all other expenses with a future value at
closing. However, the liability of such items is limited only to those items
which are 60 days old or less. All liabilities over 60 days which are unpaid
remain the responsibility of Seller. A listing of known such items at this date
are listed on "Exhibit A" (Liabilities).
2. Purchase Price and Fees.
-----------------------
(a) Purchase Price. As consideration for the purchase and sale of Seller's
--------------
TiterMax business, Buyer agrees to pay to Seller the Purchase Price, which shall
be the sum of $750,000 to be paid as follows: (i) $100,000 paid by Buyer at the
time of Closing by either certified check or wire transfer and (ii) $650,000
provided to Buyer from Seller as a senior, secured five-year note at 10%
interest in the form as attached hereto as "Exhibit B" (Secured Promissory
Note). Obligations and repayment schedule of Seller's note are described under
"Exhibit B" attached hereto. There will be no closing costs, loan points or
other fees at closing except that each party will be responsible for its own
legal expenses.
(b) Maintenance Fee. Buyer shall pay Seller $500.00 due on the first of
---------------
each month for patent maintenance fees (the "Patent Maintenance Fees"). It is
understood that TiterMax patents are part of broader patent filings for other
technologies of Seller that are not included in this Purchase Agreement
including adjuvants, DNA delivery and in use with certain purified or
restricted-weight poloxamers and compounds utilized, funded and maintained by
Seller. In the event Seller abandons any or all of its patents or certain
territories, Seller shall notify Buyer of this action, and give Buyer the right
of first refusal to purchase all of such patents or territories for nominal
consideration, not to exceed One Hundred Dollars ($100.00). In such event, Buyer
may, at its discretion, negotiate a sublicense for any Emory patents (TiterMax
Classic) and/or may choose to assume all of Seller's patent maintenance
activities and costs at that time.
3. Closing.
-------
(a) The closing (the "Closing") shall be at the office of Seller, 000
Xxxxxxxxxx Xxxxxxx, Xxxxxxxx, Xxxxxxx, commencing on or before June __, 2000.
(b) At Closing, Seller shall deliver the following to Buyer:
(1) A Xxxx of Sale, including a lien for the Secured Promissory Note,
for the Items, in the form attached hereto as Exhibit D.
(2) A license agreement (the "License TiterMax Gold Agreement"), in
form and substance acceptable to Buyer and its counsel, for
TiterMax Gold exclusive for the limited use as adjuvants in
laboratory animals.
(3) A sub-license to use TiterMax Classic for the limited use as
adjuvants in laboratory animals. The license shall not include
any rights for research use for any other reason including DNA
delivery. This license does not include a royalty-free license
with any other party including Emory or BASF.
(4) A license agreement, in form and substance acceptable to Buyer
and its counsel, for the "TiterMax" trademark shown on Exhibit C
at no cost to Buyer, which license shall be for the period of
time until the final note payment is made, at which time the
title to the "TiterMax" trademark will pass from Seller to Buyer.
(5) Assignments of all of Seller's rights in and to the distributor
agreements referenced in paragraph 1.1(vii) hereof, in form and
substance acceptable to Buyer and its counsel.
(6) A Noncompetition and Nonsolicitation Agreement in the form
attached hereto as Exhibit E.
(c) At Closing, Seller shall deliver the following to Buyer:
(1) The sum of One Hundred Thousand Dollars ($100,000.00) in cash or
other good and immediately available funds.
(2) The Secured Promissory Note in the form attached hereto as
Exhibit B.
(3) Corporate resolutions of Buyer in the form attached hereto as
Exhibit F.
(4) Buyer shall execute the license agreements referenced in paragraph
3(b)(2) and 3(b)(3) and the Noncompetition and Nonsolicitation
Agreement referenced in paragraph 3(b)(5).
(5) A personal security interest and personal guarantee of the
Secured Promissory Note by Gay X. Xxxxxxxxxx, President & CEO of
TiterMax USA, Inc.
4. Restrictions on use of TiterMax.
-------------------------------
Buyer agrees that TiterMax shall be used for the sole purpose of selling to
the research market for use in laboratory animals only. Any other use, including
use in human and veterinary vaccines or DNA delivery, are prohibited and will
result in the loss of marketing rights. Specifically, use is restricted to CRL
8300 compound for TiterMax Gold and compound L-141 (purchased from BASF) for
TiterMax Classic. No other compounds from Seller may be used.
5. Responsibilities of Buyer.
-------------------------
(a) Third Party Royalties: Buyer understands and accepts full
---------------------
responsibility for payment of all third party royalties (collectively,
the "Royalties") due and payable to Emory University and BASF pursuant
to the license agreements Seller has with such parties. Buyer will
provide Seller proof of compliance with such license agreements on a
quarterly basis. Failure to maintain these license agreements will
result in the breach of the license agreement and loss of the licenses
granted thereunder, resulting in considerable and possibly irreparable
damage to Seller. Therefore, Buyer will be in breach of this Agreement
if it breaches such license agreements. Seller attests that it is in
full compliance with such license agreements at closing.
(b) Worldwide TiterMax Trademark: Buyer shall assume direct financial
----------------------------
responsibility for the payment of TiterMax trademark annuities, annuity
prosecution and defense. Buyer will provide Seller proof of compliance
of worldwide Trademark compliance on a quarterly basis. Failure to
maintain these Trademarks will result in the loss of the Trademark
resulting in considerable and possibly irreparable damage to CytRx.
Therefore, Buyer will be in breach of this contract if it fails to
maintain such Trademarks around the world. A listing of all Trademarks
to be maintained by country is listed on "Exhibit C" (Trademarks).
(c) Life and Disability Insurance: Buyer shall purchase and maintain Life
-----------------------------
and Disability Insurance coverage for Buyer's President/CEO, naming
Seller as beneficiary. These coverages shall protect Seller's interests
in the TiterMax business in the event of the death or disability of
Buyer's President/CEO. Buyer shall provide Seller proof of such
insurance policies within 30 days of closing. Buyer will be in breach
of this contract if it fails to maintain such coverage.
(d) Financial Reports: Until the Secured Promissory Note has been paid in
-----------------
full, Buyer shall prepare, sign, attest and submit to Seller within 30
days of the close of each calendar quarter, financial disclosure
documents detailing the financial condition of the TiterMax business.
These documents shall include a current
income statement, balance sheet, accounts receivable report, and
accounts payable summary.
6. Responsibilities of Seller.
--------------------------
(a) Chemical Synthesis: Seller will provide Buyer one kilogram of the
------------------
active ingredient for TiterMax Gold and Seller's inventory of TiterMax
Classic except 500 grams of TiterMax Classic (these items hereinafter,
the "Reserve Inventory") which Seller will retain in its inventory.
Seller shall provide Buyer with one (1) additional kilogram of the
active ingredient for TiterMax Gold within two (2) months of Closing.
Seller shall release the Reserve Inventory to Buyer at no additional
cost when Buyer pays off the Secured Promissory Note attached hereto as
Exhibit B. Future supplies (batches) shall be at the option of both
parties. If Seller is unable or unwilling to synthesize additional
materials, Seller shall provide Buyer with the know-how to develop the
materials or have the materials developed by another party.
(b) Patent Prosecution: Seller accepts liability for patent prosecution
------------------
costs incurred prior to closing.
(c) Marketing Activities: Seller agrees to support the current marketing
--------------------
plans of the TiterMax brand prior to closing, including attendance at
Trade Shows and related promotional programs.
(d) Emory License: Subject to the provisions of paragraph 2(b), Seller
-------------
agrees to keep the Emory license in full force and effect to the best
ability of Seller, except for the payment of third party royalties,
which shall be Buyer's responsibility.
7. Miscellaneous.
-------------
(a) Notice: Any notices given under this Agreement shall be deemed to be
------
effectively given when delivered personally or five days after being
placed in the United States mail, postage prepaid, certified or
registered mail or one day after being sent via air courier, addressed,
in the case of Seller, as follows:
CytRx Corporation
000 Xxxxxxxxxx Xxxxxxx
Xxxxxxxx, Xxxxxxx 00000
Attention: Xxxx Xxxxxxx
with a copy to:
Xxxxxx & Bird
One Atlantic Center
0000 X. Xxxxxxxxx Xxxxxx
Xxxxxxx, Xxxxxxx 00000-0000
Attention: Xxxxxx Xxxxxxx
and in the case of Buyer, as follows:
TiterMax USA, Inc.
0000 Xxxx Xxxx # 000-00
Xxxxxxxx, Xxxxxxx 00000
Attention: Gay X. Xxxxxxxxxx
with copy to:
Xxxxxx X. Nephew, P.C.
0000 Xxxxxxxxx Xxxxxxx, X.X.
Building One, Suite 200
Atlanta, Georgia 30327
(b) Binding Effect and Counterparts. This Agreement shall be binding upon
-------------------------------
and shall inure to the benefit of the parties hereto and their
successors and assigns.
(c) Governing Law. This Agreement and all rights and obligations of the
-------------
parties shall be governed, construed and interpreted under and
pursuant to the laws of the State of Georgia.
(d) Termination. This Agreement may be terminated at any time prior to the
-----------
Closing Date by (i) mutual consent of the parties hereto; (ii) the
Buyer if any of the conditions of its obligations hereunder shall not
have been satisfied at or prior to the Closing on the Closing Date and
(if not satisfied) shall not have been waived by Buyer; (iii) the
Seller if any of the conditions of its obligations hereunder shall not
have been satisfied at or prior to the Closing on the Closing Date and
(if not satisfied) shall not have been waived by Seller; or (iv) by
either party if the Closing has not occurred by June __, 2000 and the
terminating party has not breached the terms of this Agreement. If the
parties hereto have not reached agreement on the form and substance of
the closing documents referenced in paragraph 3, either party may
terminate this Agreement and neither party shall owe any further duties
to the other.
(e) Survival. The completion of the sale hereunder shall not terminate any
--------
of the covenants, representations, warranties or liabilities of the
parties under this Agreement, and the same shall continue and survive
the completion of the sale.
(f) Entire Agreement; Modifications. This Agreement supersedes all prior
-------------------------------
negotiations between the parties hereto and contains the entire
understanding between them. It may be modified only by a writing duly
executed by each of the parties hereto or their successors or assigns.
(g) Negotiated Transaction. The provisions of this Agreement were
----------------------
negotiated by the parties hereto and this Agreement shall be deemed to
have been drafted by all the parties hereto, notwithstanding any
presumptions at law to the contrary.
(h) Further Assurances. After the Closing, the parties, at the request of
------------------
the other or others, shall promptly execute, deliver, or cause to be
executed or delivered, any documents and instruments requested by the
other or others in addition to those required by this Agreement, in
form and substance reasonably satisfactory to the other or others, as
the other or others my deem necessary to carry out the terms of this
Agreement.
(i) Expenses. Each of the parties shall pay its own expenses and the fees
--------
and expenses of its counsel, accountants, and other experts in
connection with this Agreement.
(j) Attorney's Fees to Prevailing Party. The prevailing party in any
-----------------------------------
litigation with respect to this Agreement or the transactions
contemplated hereby shall be entitled to recover from the non-
prevailing party its reasonable attorney's fees and costs of
litigation.
(k) Publicity. The parties agree that the content and timing of any press
---------
release of other public announcement concerning the transaction
described in this Agreement are subject to the prior approval of the
Seller.
(l) Approval. The undersigned officers represent and warrant that their
--------
execution of this Agreement on behalf of their respective corporations
has been authorized (or will be ratified) by the Board of Directors of
their respective corporations. If the execution of this Agreement has
not been aurthorized or is not subsequently ratified by the Board of
Directors of either corporation, this Agreement shall be rescinded and
all compensation paid by Buyer shall be immediately returned to Buyer,
and all items conveyed to Buyer by Seller pursuant to this Agreement
shall be immediately returned to Seller.
SELLER BUYER
CYTRX CORPORATION TITERMAX USA, INC.
By: ____________________ By: ____________________
Name: Xxxx X. Xxxxxxx Name: Gay X. Xxxxxxxxxx
Title: President & CEO Title: President & CEO
Date: __________________ Date: __________________
Attachments: Exhibit A (Liabilities)
Exhibit B (Secured Promissory Note)
Exhibit C (Trademarks)
Exhibit D (Xxxx of Sale)
Exhibit E (Noncompetition and Nonsolicitation Agreement)
Exhibit F (Buyer's Corporate Resolutions)
